Astellas Announces U.S. FDA Grants Priority Review for Zolbetuximab Biologics License Application ...Middle East

If approved, the investigational therapy would offer a new treatment option for patients with advanced gastric and gastroesophageal cancers TOKYO, July 6, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food...

Hence then, the article about astellas announces u s fda grants priority review for zolbetuximab biologics license application was published today ( Thursday 06/07/2023 - 09:08 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Astellas Announces U.S. FDA Grants Priority Review for Zolbetuximab Biologics License Application )

Also on site :

• My Big Family Once Formed the Backbone of My Life. Then, We Discovered My Sister’s Horrific Actions. Now Nothing Is the Same.
• Royal Caribbean Extends Pause at Private Caribbean Resort Through 2026—Here’s What Cruisers Are Getting Instead
• HomeGoods' Gorgeous New Valentine's Glassware Has Shoppers Saying: 'I Need It All'